Ozempic is dedicated to managing type 2 diabetes, whereas Wegovy is crafted for chronic weight management in context with necessary clinical trials and FDA labeling
Patients with the following conditions should avoid FDA-approved semaglutide products: Personal or family history of medullary thyroid carcinoma (MTC) Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) Severe allergic reactions to semaglutide History of pancreatitis Diabetic retinopathy Kidney problems Serious stomach issues Pregnancy or breastfeeding Compounded semaglutide , lacking FDA approval, does not have the same established safety guidelines or defined patient populations
Patients receiving tirzepatide also had lower risks of cardiovascular outcomes like myocardial infarction, heart failure and heart failure exacerbations
Originally for diabetes but works great for weight loss too - people just naturally eat less because they're satisfied with smaller portions
It is important to note that vitamin B12 cannot be synthesised by the human body and must be obtained through dietary sources or supplementation
Regulatory pathways supporting quality-assured alternatives continue to be important in improving treatment accessibility while maintaining standards of safety, efficacy, and quality